Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib Plus Dexamethasone for Acquired Pure Red Cell Aplasia
NCT04423367Phase 2Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Sep 2020
- Primary completion
- Jul 2024
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in acquired pure red cell aplasia (PRCA), sponsored by Institute of Hematology and Blood Diseases Hospital. Started Sep 2020; status: completed.
02
Drugs
bortezomib
03
Conditions
acquired pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on NCT04423367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04423367.